Search Results

- Company listed in Research and Markets’ announcement and description of new research report on the U.S. Breast Cancer Screening and Diagnostic Market- - “U.S. breast cancer screening and diagnostic [device] market was valued at $1.55 billion in 2024 and is anticipated to reach $2.34 billion by the end of 2030, at a CAGR of 7.05% during the forecast period 2024-20301"- -Report supports Company’s regulatory strategy for IzoView Breast CT, reinforces high demand for new breast imaging modalities, strengthens the potential for rapid market adoption and significant market share -

Now celebrating its 50th Anniversary, the National Foundation for Cancer Research will unite the world’s leading cancer researchers, clinicians, entrepreneurs, and biotech leaders for its 2023 Global Summit and Award Ceremonies for Cancer Research & Entrepreneurship on Saturday, October 21, 2023, at The National Press Club in Washington, D.C.

A team of investigators at City of Hope funded by the Prostate Cancer Foundation reports that patients with advanced prostate cancer can be safely treated with chimeric antigen receptor T cell therapy.

The Rare Cancer Research Foundation is proud to announce an exciting collaboration with Spanios aimed at propelling the discovery and validation of groundbreaking therapeutic options for rare cancers.